Lulin Ma

机构：Peking University, Peking University Third Hospital · ORCID：0000-0003-2141-9348

发表论文 185 篇 · 总被引 2108 次 · h-index 23

代表论文

• Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial (2024 · Journal of Clinical Oncology · 被引 156)
• Neoadjuvant stereotactic ablative body radiotherapy combined with surgical treatment for renal cell carcinoma and inferior vena cava tumor thrombus: a prospective pilot study (2024 · BMC Urology · 被引 13)
• First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 10)
• Untargeted metabolomics and mendelian randomization analysis identify alpha-linolenic acid and linoleic acid as novel biomarkers of perioperative neurocognitive dysfunction (2024 · Clinical Nutrition · 被引 9)
• Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer (2024 · Cancer Biology and Medicine · 被引 9)
• Radiomics for differential diagnosis of Bosniak II-IV renal masses via CT imaging (2024 · BMC Cancer · 被引 4)